Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00963911 · OUTCOME

Specificity of the G8 Questionnaire

Validation of a Screening Tool in Geriatric Oncology · Source last updated 2021-04-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
% of Participants with a negative G8
Interval / dispersion
95% Confidence Interval
Time frame
at inclusion (at completion of the G8 questionnaire)

What was measured

Specificity of the G8 questionnaire measured as percentage of participants with a negative G8 test among patients with a negative MGA.The G8 consists of eight items: patient age (\>85, 80-85, \<80), and seven items from the original 18-item MNA (Mini Nutritional Assessment: appetite changes, weight loss, mobility, neuropsychological problems, body mass index, medication, and self-rated health). The total score ranges from 0 to 17, with lower scores indicating a higher risk of impairments. The cut-off value for an 'impaired' reference test score was \<=14. Multidimensional geriatric assessment (MGA): Patients underwent a geriatric evaluation in the month following the completion of VES-13. The nurse completed six instruments of the MGA (MNA, Timed Get up and Go, Activities of Daily Living (ADL), Instrumental ADL, Mini Mental State Examination, and Geriatric Depression Scale, and the geriatrician rated comorbidity on the Cumulative Illnes Rating Scale.

Analysis population: Eligible patients assessable for the primary outcome measure AND with a negative MGA

Groups in this outcome

Eligible Patients Assessable for the Primary Outcome Measure

Patients older than 70 years and included either before any first-line treatment, or between any two steps of a pre-defined first-line treatment sequence (chemotherapy, endocrine therapy, targeted treatment, surgery or radiotherapy) for various types of histologically-confirmed cancer (colon, lung, upper aero digestive tract (UAT)/head and neck, breast, prostate, and non-Hodgkin's lymphomas (NHL)), and for whom G8 as well as at least one instrument of the multidimensional assessment were available.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Eligible Patients Assessable for the Primary Outcome Measure284

Reported measurements

Source class 1
Values in % of Participants with a negative G8 · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Eligible Patients Assessable for the Primary Outcome Measure64.4Not reported58.670.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        58.6
        upper Limit
        70.0
        value
        64.4
denoms
  1. counts
    1. group Id
      OG000
      value
      284
    units
    Participants
description
Specificity of the G8 questionnaire measured as percentage of participants with a negative G8 test among patients with a negative MGA.The G8 consists of eight items: patient age (\>85, 80-85, \<80), and seven items from the original 18-item MNA (Mini Nutritional Assessment: appetite changes, weight loss, mobility, neuropsychological problems, body mass index, medication, and self-rated health). The total score ranges from 0 to 17, with lower scores indicating a higher risk of impairments. The cut-off value for an 'impaired' reference test score was \<=14. Multidimensional geriatric assessment (MGA): Patients underwent a geriatric evaluation in the month following the completion of VES-13. The nurse completed six instruments of the MGA (MNA, Timed Get up and Go, Activities of Daily Living (ADL), Instrumental ADL, Mini Mental State Examination, and Geriatric Depression Scale, and the geriatrician rated comorbidity on the Cumulative Illnes Rating Scale.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients older than 70 years and included either before any first-line treatment, or between any two steps of a pre-defined first-line treatment sequence (chemotherapy, endocrine therapy, targeted treatment, surgery or radiotherapy) for various types of histologically-confirmed cancer (colon, lung, upper aero digestive tract (UAT)/head and neck, breast, prostate, and non-Hodgkin's lymphomas (NHL)), and for whom G8 as well as at least one instrument of the multidimensional assessment were available.
    id
    OG000
    title
    Eligible Patients Assessable for the Primary Outcome Measure
param Type
NUMBER
population Description
Eligible patients assessable for the primary outcome measure AND with a negative MGA
reporting Status
POSTED
time Frame
at inclusion (at completion of the G8 questionnaire)
title
Specificity of the G8 Questionnaire
type
SECONDARY
unit Of Measure
% of Participants with a negative G8

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice